- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Dag Kvale
Total 3539 results
-
Chong Kun Dang PharmaceuticalCompletedLiver DysfunctionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownRheumatoid ArthritisKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedOsteoarthritis of the KneeKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownEssential HypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownMixed HyperlipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedHypertension | HyperlipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalTerminatedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknown
-
Chong Kun Dang PharmaceuticalUnknownEvidence of Liver TransplantationKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEssential Hypertension | HyperlipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedHealthy Male Volunteers
-
Chong Kun Dang PharmaceuticalCompletedAdvanced Solid CancersKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedHealthy Male VolunteerKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruiting
-
Chong Kun Dang PharmaceuticalRecruitingKidney TransplantKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingCOVID-19 PneumoniaKorea, Republic of
-
Chong Kun Dang PharmaceuticalNot yet recruitingKidney TransplantationKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedKidney TransplantKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEndocrine, Nutritional and Metabolic DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes type2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHealthy SubjectsUnited Kingdom
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedClinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy VolunteersChronic Renal FailureKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Dar El Oyoun HospitalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedAlopeciaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEfficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedChronic Hepatitis BKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of